Semaglutide | Peptide Encyclopedia | Auryx
Semaglutide is a physician-reviewed Auryx Learn encyclopedia entry. A long-acting GLP-1 receptor agonist that suppresses appetite, slows gastric emptying, and improves insulin sensitivity for sustained fat loss. This page is educational. It is not a dosing guide and not a substitute for a licensed clinician.
How it works
Semaglutide mimics glucagon-like peptide-1 (GLP-1), a gut hormone released after eating. By binding GLP-1 receptors in the pancreas, gut, and brain, it reduces hunger signals, delays gastric emptying, and improves glucose-dependent insulin secretion — creating a meaningful caloric deficit without direct stimulant effects.
- Significant reduction in body weight and fat mass
- Improved fasting glucose and HbA1c
- Appetite suppression at neurological level
- Cardiovascular risk reduction in metabolic disease
Used for medically supervised weight loss and metabolic health improvement in individuals with obesity or metabolic syndrome.
Studied extensively in clinical research for its role in GLP-1 receptor biology and metabolic regulation.
Clinic context and next steps
Pair this entry with the matching shop listing when Auryx offers the compound, or browse the full encyclopedia. Category shopping lives under shop. Mechanism language is not a personal outcome and does not approve a protocol.
Auryx is an MD-led telemedicine clinic. Eligible patients complete remote intake; compounds ship from regulated United States compounding pharmacies after clinical review. Use the protocol finder if you are matching a goal, our method for the four-step process, and about for physician leadership. Citations sit on sources. Questions go to contact or info@auryxlife.com.
Nothing on Learn diagnoses, treats, cures, or prevents disease. Read privacy and terms before you share health information. Language homepages: español and português.